Biogen’s ZURZUVAE Wins EU Approval for Postpartum Depression
Biogen (NASDAQ:BIIB) has received European Commission (EC) approval for ZURZUVAE® (zuranolone), marking...
Biogen (NASDAQ:BIIB) has received European Commission (EC) approval for ZURZUVAE® (zuranolone), marking...